3-129436620-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001276270.2(MBD4):āc.1024T>Cā(p.Ser342Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0147 in 1,614,052 control chromosomes in the GnomAD database, including 1,294 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001276270.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MBD4 | NM_001276270.2 | c.1024T>C | p.Ser342Pro | missense_variant | 3/8 | ENST00000429544.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MBD4 | ENST00000429544.7 | c.1024T>C | p.Ser342Pro | missense_variant | 3/8 | 1 | NM_001276270.2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0407 AC: 6198AN: 152116Hom.: 380 Cov.: 32
GnomAD3 exomes AF: 0.0243 AC: 6104AN: 251338Hom.: 341 AF XY: 0.0261 AC XY: 3547AN XY: 135860
GnomAD4 exome AF: 0.0119 AC: 17452AN: 1461818Hom.: 914 Cov.: 33 AF XY: 0.0142 AC XY: 10313AN XY: 727208
GnomAD4 genome AF: 0.0408 AC: 6206AN: 152234Hom.: 380 Cov.: 32 AF XY: 0.0408 AC XY: 3041AN XY: 74448
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | - - |
MBD4-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 23, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at